You are here

Language:

Frédéric Chevallier

Frédéric Chevallier

Partner

Frédéric is an IP litigator with particular experience in the Life sciences and TMT fields.

Share

Experience

Frédéric is a partner in the firm's Intellectual Property practice in Paris specialising in cross-border litigation, including the related regulatory aspects in the pharmaceutical field. He has developed particularly strong expertise in the life sciences and TMT fields, being involved in a number of major and high value patent cases for leading innovator pharmaceutical companies and leading TMT actors.

Frédéric’s practice notably focuses on representing pharmaceutical innovators and high-tech companies in cross-border patent litigation involving numerous jurisdictions. He also has extensive experience in both advising and acting in Intellectual Property disputes in France, including for trademark and copyright related advice and disputes.  

Frédéric’s experience includes advising:
 

  • Major international pharmaceutical companies on the enforcement of patent and SPC rights on antibodies, small molecules, and second medical use claims, including in preliminary injunction and provisional damages proceedings
  • International companies on the remuneration of their employee inventors and assignment of inventions
  • Major oil companies on the enforcement of their Intellectual Property rights
  • Major French and foreign smartphone and networks providers on the pan-European enforcement of their Intellectual Property rights, including their copyright, models and standard essential patents (FRAND).
 
 

Background

Prior to joining Herbert Smith Freehills, Frédéric was counsel in the IP department of an international law firm in Paris.

Related content

11th October 2022
After years of debate, Europe's new patent regime is gearing up for launch. We assess...
11th October 2022
Following a lengthy consultation, the Preparatory Committee for the Unified Patent Court (UPC) published its...
11th October 2022
The UPC will have a Court of First Instance (divided into local, regional and central...
11th October 2022
On July 2022 the UPC Rules of Procedure (the Rules) were announced as approved with...